Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 693203
HGNC: 32874
Ensembl: ENSG00000208022
miRBase:
Variants:
dbSNP: 693203
ClinVar: 693203
TCGA: ENSG00000208022
COSMIC: MIR618
RNA/Proteins
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA443937 | Drug Toxicity | Disease | VariantAnnotation | not associated | PD | ||
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Disease | VariantAnnotation | not associated | PD | ||
| PA448492 | asparaginase | Chemical | VariantAnnotation | not associated | PD | ||
| PA449165 | cyclophosphamide | Chemical | VariantAnnotation | not associated | PD | ||
| PA449177 | cytarabine | Chemical | VariantAnnotation | not associated | PD | ||
| PA449212 | daunorubicin | Chemical | VariantAnnotation | not associated | PD | ||
| PA450379 | mercaptopurine | Chemical | VariantAnnotation | not associated | PD | ||
| PA450428 | methotrexate | Chemical | VariantAnnotation | not associated | PD | ||
| PA451100 | prednisone | Chemical | VariantAnnotation | not associated | PD | ||
| PA451879 | vincristine | Chemical | VariantAnnotation | not associated | PD |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 35199612 | 2022 | Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4. | 8 |
| 35505304 | 2022 | CircRNA circ-ATAD1 suppresses miR-618 maturation to participate in colorectal cancer. | 3 |
| 35199612 | 2022 | Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4. | 8 |
| 35505304 | 2022 | CircRNA circ-ATAD1 suppresses miR-618 maturation to participate in colorectal cancer. | 3 |
| 33804070 | 2021 | Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer. | 4 |
| 34848810 | 2021 | Polymorphism rs2682818 participates in the progression of colorectal carcinoma via miR-618-TIMP1 regulatory axis. | 0 |
| 33804070 | 2021 | Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer. | 4 |
| 34848810 | 2021 | Polymorphism rs2682818 participates in the progression of colorectal carcinoma via miR-618-TIMP1 regulatory axis. | 0 |
| 32364585 | 2020 | miR-618 rs2682818 C>A polymorphism decreases Hirschsprung disease risk in Chinese children. | 4 |
| 32364585 | 2020 | miR-618 rs2682818 C>A polymorphism decreases Hirschsprung disease risk in Chinese children. | 4 |
| 30737902 | 2019 | miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-β2. | 11 |
| 31383788 | 2019 | Does miR-618 rs2682818 variant affect cancer susceptibility? Evidence from 10 case-control studies. | 4 |
| 31386627 | 2019 | Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom. | 13 |
| 30737902 | 2019 | miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-β2. | 11 |
| 31383788 | 2019 | Does miR-618 rs2682818 variant affect cancer susceptibility? Evidence from 10 case-control studies. | 4 |
Citation
Dessen P
MIR618 (microRNA 618)
Atlas Genet Cytogenet Oncol Haematol. 2015-02-01
Online version: http://atlasgeneticsoncology.org/gene/54958/mir618-(microrna-618)
